Botryoid Rhabdomyosarcoma — Clinical Trials

MONDO:00025782 activeLast updated: Mar 19, 2026, 2:57 AM

Trial Landscape

Botryoid Rhabdomyosarcoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure2

Biological Therapy2

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 3

Sponsor Types

NIH1Collaborative Network1

Trial Locations

United States2 trials

Australia2 trials

Canada2 trials

Puerto Rico2 trials

New Zealand1 trial

Saudi Arabia1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 3Active, Not Recruiting

NCT02567435

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jun 2016Est. completion: Oct 2026Updated: Mar 2026

Phase 3Active, Not Recruiting

NCT04994132

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Sponsor:Children's Oncology Group

United StatesStarted: Sep 2021Est. completion: Jun 2026Updated: Feb 2026

Stay informed about clinical trials for Botryoid Rhabdomyosarcoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 2:57 AM